Immune checkpoint inhibitors improve the efficacy of neoadjuvant chemotherapy in advanced gastric cancer: a retrospective cohort study
Adding ICIs to NAC regimens in AGC significantly improves pathological response. While overall toxicity is not increased, close monitoring for irAEs is necessary.
Authors
- Yonghe Chen (ORCID: https://orcid.org/0000-0001-5957-3872)
- Yi Lin (ORCID: https://orcid.org/0000-0003-2875-7542)
- Lei Lian (ORCID: https://orcid.org/0000-0002-8895-7792)
- Gang Liu (ORCID: https://orcid.org/0000-0002-8322-6587)
- Shuai Ye
- Junsheng Peng (ORCID: https://orcid.org/0000-0002-7129-8954)
- Yingying Xu (ORCID: https://orcid.org/0000-0003-4924-9379)
- Jianwei Zhang (ORCID: https://orcid.org/0000-0001-7213-0128)
- Shi Chen (ORCID: https://orcid.org/0009-0003-9920-0247)
Institutions
- Sun Yat-sen University (CN)
- Sixth Affiliated Hospital of Sun Yat-sen University (CN)
Publication Details
- Journal
- Therapeutic Advances in Medical Oncology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/17588359251346423
- Citations
- 2
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 3.04
Funders
- National Natural Science Foundation of China